Hypothesis: Human Umbilical Cord Blood-derived Stromal Cells Promote Megakaryocytopoiesis Through the Influence of SDF-1 and PECAM-1

Cell Biochemistry and Biophysics

Volumn 58, Issue 1, 2010, Pages 25-30

  Feng, Yimei ^a   Chen, Xinghua ^a   Gao, Lei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hematopoietic microenvironment; Megakaryocytopoiesis; Platelet endothelial cell adhesion molecule 1; Stromal cell derived factor 1; Stromal cells; Umbilical cord blood

Indexed keywords

CD31 ANTIGEN; CXCL12 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CELL CULTURE; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; PHYSIOLOGY; STROMA CELL; THROMBOCYTOPOIESIS;

ANTIGENS, CD31; CELLS, CULTURED; CHEMOKINE CXCL12; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; STROMAL CELLS; THROMBOPOIESIS;

EID: 77955658462     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9086-z     Document Type: Article

References (38)

1. Timmer-Bonte, J. N., Adang, E. M., Termeer, E., Severens, J. L., & Tjan-Heijnen, V. C. (2008). Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy. Journal of Clinical Oncology, 26, 290-296.
2. Dhanjal, T. S., Pendaries, C., Ross, E. A., Larson, M. K., Protty, M. B., Buckley, C. D., et al. (2007). A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood, 109, 4237-4244.
3. Gao, L., Chen, X. H., Feng, Y. M., Zhang, X., Yu, S. C., Zhang, C., et al. (2010). Human umbilical cord blood-derived stromal cells: Multifaceted regulators of megakaryocytopoiesis. Cell Cycle, 9, 1-12.
4. Slayton, W. B., Wainman, D. A., Li, X. M., Hu, Z. B., Jotwani, A., Cogle, C. R., et al. (2005). Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells, 23, 1400-1408.
5. Deutsch, V., Hubel, E., Kay, S., Ohayon, T., Katz, B., Many, A., et al. (2010). Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood. British Journal of Haematology, 149, 137-149.
6. Nagahisa, H., Nagata, Y., Ohnuki, T., Osada, M., Nagasawa, T., Abe, T., et al. (1996). Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood, 87, 1309-1316.
7. Nishida, S., Endo, N., Yamagiwa, H., Tanizawa, T., & Takahashi, H. E. (1999). Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. Journal of Bone and Mineral Metabolism, 17, 171-177.
8. Stenderup, K., Justesen, J., Clausen, C., & Kassem, M. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33, 919-926.
9. Gao, L., Chen, X., Zhang, X., Liu, Y., Kong, P., Peng, X., et al. (2006). Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro. Blood Cells, Molecules, and Diseases, 36, 322-328.
10. Oostendorp, R. A., Robin, C., Steinhoff, C., Marz, S., Brauer, R., Nuber, U. A., et al. (2005). Long-term maintenance of hematopoietic stem cells does not require contact with embryo-derived stromal cells in cocultures. Stem Cells, 23, 842-851.
11. Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., et al. (2004). Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nature Medicine, 10, 64-71.
12. Nagasawa, T., Kikutani, H., & Kishimoto, T. (1994). Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proceedings of the National Academy of Sciences of the United States of America, 91, 2305-2309.
13. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., et al. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382, 635-638.
14. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature, 393, 595-599.
15. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., et al. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature, 382, 829-833.
16. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). Journal of Experimental Medicine, 184, 1101-1109.
17. Hidalgo, A., Sanz-Rodriguez, F., Rodriguez-Fernandez, J. L., Albella, B., Blaya, C., Wright, N., et al. (2001). Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Experimental Hematology, 29, 345-355.
18. Lataillade, J. J., Clay, D., Bourin, P., Herodin, F., Dupuy, C., Jasmin, C., et al. (2002). Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood, 99, 1117-1129.
19. Lataillade, J. J., Clay, D., Dupuy, C., Rigal, S., Jasmin, C., Bourin, P., et al. (2000). Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood, 95, 756-768.
20. Hamada, T., Mohle, R., Hesselgesser, J., Hoxie, J., Nachman, R. L., Moore, M. A., et al. (1998). Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. Journal of Experimental Medicine, 188, 539-548.
21. Hodohara, K., Fujii, N., Yamamoto, N., & Kaushansky, K. (2000). Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood, 95, 769-775.
22. Newman, P. J., & Newman, D. K. (2003). Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 953-964.
23. Wu, Y., Welte, T., Michaud, M., & Madri, J. A. (2007). PECAM-1: a multifaceted regulator of megakaryocytopoiesis. Blood, 110, 851-859.
24. Couty, J. P., Rampon, C., Leveque, M., Laran-Chich, M. P., Bourdoulous, S., Greenwood, J., et al. (2007). PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. Journal of Neurochemistry, 103, 793-801.
25. Wang, Y., & Sheibani, N. (2006). PECAM-1 isoform-specific activation of MAPK/ERKs and small GTPases: implications in inflammation and angiogenesis. Journal of Cellular Biochemistry, 98, 451-468.
26. Baumann, C. I., Bailey, A. S., Li, W., Ferkowicz, M. J., Yoder, M. C., & Fleming, W. H. (2004). PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors. Blood, 104, 1010-1016.
27. Mahooti, S., Graesser, D., Patil, S., Newman, P., Duncan, G., Mak, T., et al. (2000). PECAM-1 (CD31) expression modulates bleeding time in vivo. American Journal of Pathology, 157, 75-81.
28. Ross, E. A., Freeman, S., Zhao, Y., Dhanjal, T. S., Ross, E. J., Lax, S., et al. (2008). A novel role for PECAM-1 (CD31) in regulating haematopoietic progenitor cell compartmentalization between the peripheral blood and bone marrow. PLoS ONE, 3, e2338.
29. Tong, W., & Lodish, H. E. (2004). Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. Journal of Experimental Medicine, 200, 569-580.
30. Basser, R. (2002). The impact of thrombopoietin on clinical practice. Current Pharmaceutical Design, 8, 369-377.
31. Minamiguchi, H., Kimura, T., Urata, Y., Miyazaki, H., Bamba, T., Abe, T., et al. (2001). Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways. British Journal of Haematology, 115, 175-185.
32. Broxmeyer, H. E. (2008). Chemokines in hematopoiesis. Current Opinion in Hematology, 15, 49-58.
33. Nagasawa, T. (2007). The chemokine CXCL12 and regulation of HSC and B lymphocyte development in the bone marrow niche. Advances in Experimental Medicine and Biology, 602, 69-75.
34. Li, K., Yang, M., Lam, A. C., Yau, F. W., & Yuen, P. M. (2000). Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplantation, 9, 125-131.
35. Williams, J. L., Pipia, G. G., Datta, N. S., & Long, M. W. (1998). Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood, 91, 4118-4126.
36. van den Oudenrijn S, v. d. B. A., de Haas, M. (2000). Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Experimental Hematology, 28, 1054-1061.
37. Zhang, X. F., Wang, J. F., Matczak, E., Proper, J. A., & Groopman, J. E. (2001). Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood, 97, 3342-3348.
38. Guerriero, R., Mattia, G., Testa, U., Chelucci, C., Macioce, G., Casella, I., et al. (2001). Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood, 97, 2587-2595.